Autor: |
C. Diaz-Pedroche, Florian Posch, M.D.C. Beato Zambrano, D. Pesantez, M. Aramberri, Carme Font, D. Muñoz Guglielmetti, Cihan Ay |
Rok vydání: |
2019 |
Předmět: |
|
Zdroj: |
Annals of Oncology. 30:v724 |
ISSN: |
0923-7534 |
DOI: |
10.1093/annonc/mdz265.019 |
Popis: |
Background Pulmonary embolism (PE) is a common condition in patients with cancer, having a wide spectrum of clinical presentation (from acute life-threatening to truly asymptomatic incidental events). The aim of this study was to assess the prognostic relevance of the variable ‘setting’ (hospital-acquired vs. outpatient) at PE diagnosis. Methods Multicenter observational ongoing registry of consecutive patients with cancer-associated PE (2005-2018) including incidental and acute symptomatic events. The main outcome measured was the rate of overall and PE-specific 30-day mortality. Secondary outcomes were: rates of 30-day major bleeding (MB) and venous thromboembolism (VTE) recurrence. Results We included a total of 617 patients (61.6% male; median age 65 + 11.4 years; range 19-91 years) including N = 522 (85%) outpatients and N = 95 (15%) inpatients at PE diagnosis. The most frequent primary tumors were: lung 32%, colorectal 14%, urologic 13%, upper GI 12%, breast 9%, gynecologic 6% and other 9%). Most of the patients (79%) had metastatic cancer and nearly half (47%) were receiving chemotherapy.The PE was incidentally found in 54% of the cases. Overall 30-day mortality occurred in 95 patients (15% of the cohort), being greater in inpatients compared to outpatients (30% vs. 13%; p Conclusions Hospital-acquired PE in cancer patients was associated with a greater overall 30-day mortality compared to outpatients at PE diagnosis. This finding may be relevant for the development of PE risk-assessment models in this setting. Legal entity responsible for the study Hospital Clinic de Barcelona. Funding Has not received any funding. Disclosure All authors have declared no conflicts of interest. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|